Companies /Basic Materials

Warrior Met Coal Inc

NYSE: HCC Coking Coal
$93.07
▲ $3.27 (+3.64%) today
Markets closed · 10:54pm ET

24/7 Wall St. View

HCC at a Glance

Valuation
Market cap
$4.9B
P/E ratio
22.4
Dividend yield
0.36%
Profitability
Revenue (TTM)
$1.7B
Profit margin
13.0%
EPS (TTM)
$4.16
Price
52-week range
$62 – $111
24/7 target
$92.84
Street target
$110.00
Earnings
Next report
Nov 4, 2026
Q2 2026 EPS
$1.65
vs. $1.46 est.
+13.1%

Headquartered in Brookwood, AL Fiscal year ends December NYSE: HCC warriormetcoal.com

About Warrior Met Coal

Warrior Met Coal, Inc. is a U.S.-based producer and exporter of premium high-quality metallurgical (met) steelmaking coal, also known as hard-coking coal (HCC), used as a critical component in steel production by metal manufacturers globally. The company operates highly efficient longwall underground mines in Alabama, producing coal from the Blue Creek coal seam, which is characterized by very low sulfur content and strong coking properties that make it ideally suited as a base feed coal for steelmakers. Warrior serves customers in Europe, South America, and Asia, and is dedicated entirely to non-thermal met coal production. The company's operations include the recently ramped-up Blue Creek mine, which has significantly expanded its production capacity, lowered its unit cost structure, and diversified its product offering to include high-vol A steelmaking coal alongside its premium low-vol product. Warrior benefits from the Section 45X Advanced Manufacturing Production Tax Credit for its coal production. The company exports its product primarily through the McDuffie Terminal at the Port of Mobile, Alabama. Updated

HCC Coverage

Frequently Asked Questions

What does Warrior Met Coal do?

Warrior Met Coal, Inc. is a U.S.-based producer and exporter of premium high-quality metallurgical (met) steelmaking coal, also known as hard-coking coal (HCC), used as a critical component in steel production by metal manufacturers globally.

What is the HCC stock price target?

24/7 Wall St.'s 12-month price target for HCC is $92.84, rated Hold. The Wall Street consensus target is $110.00. HCC price prediction →